T-Bolic – Turinabol 10mg
(4-Chlorodehydromethyltestosterone)

T-bolic is presented in the ORYVION catalog as a tablet formulation containing 10 mg of Turinabol (4-Chlorodehydromethyltestosterone) per tablet, supplied in containers of 50 tablets. Turinabol is a synthetic, orally active anabolic-androgenic steroid.

Its pharmacological profile includes androgen receptor activity and effects on protein metabolism. It has been used non-medically in sports and bodybuilding with the aim of increasing muscle mass and strength. 

Product Specifications:
Commercial name: T-Bolic
Listed compound: Turinabol (4-Chlorodehydromethyltestosterone)
Declared strength: 10 mg per tablet
Format: Tablets
Package contents: 50 tablets

Important Note:
As a 17α-alkylated anabolic-androgenic steroid, Turinabol carries a risk of serious liver injury, including cholestasis. Anabolic-androgenic steroid use can also adversely affect cholesterol levels, suppress natural testosterone production, and impair fertility.


Legal Disclaimer
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.

ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.

By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.

ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.